RxDoctor Payments Data

Emily Bennett, OD

Optometrist · Midlothian, VANPI 1245856970

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,060 of the $6,994 with a category attached, or 72.4%. 22 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 30.7% of the total. Reporting peaked in 2024 at $2,971 and has fallen 53.6% since, to $1,379 in 2025. Among optometrist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,994in general payments, 2019–2025

Across 118 payments — averaging $59.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$2K
  • Bausch & Lomb Americas Inc.$1K
  • Johnson & Johnson Surgical Vision, Inc.$659
  • Alcon$456
  • AbbVie$367
  • Optos, Inc.$262
  • plus $2K from 16 others

What the payments were for

  • Travel & lodging$1,67124%
  • Food & beverage$5,06072%
  • Entertainment$2624%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,994 in reported general payments places this provider in the 95th percentile of 1,230 optometrist providers in Virginia.

See all optometrist providers in Virginia

Medicare billing

Part B allowed, 2024
$50,972
Medicare patients
295
Services billed
584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate31$886
Latanoprost77$793
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha26$303
Timolol Maleate24$233

Paid to pharmacies, not to this prescriber.

Other optometrist in Midlothian

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →